NASDAQ:ABUS 17 January 2026

Pfizer stock slips into holiday week as CEO filing, vaccine-policy row and biotech IPO news land

Pfizer shares closed down 0.9% at $25.65 Friday after CEO Albert Bourla disclosed a phantom-stock award and expressed frustration over U.S. vaccine policy changes. A European patent ruling kept COVID-era lawsuits in focus. Investors await Tuesday’s open after the holiday and Pfizer’s February 3 results update.

17 January 2026

NASDAQ:ABUS·NYSE:PFE·Pharmaceuticals·Stock Market

SkyWest (SKYW) Share Price Pullback Sparks Reassessment Amid Valuation Discrepancies
March 20, 2026, 2:26 PM EDT. SkyWest's stock recently dipped 0.2% in a week and 16.8% over 30 days, closing at $89.36. Despite lagging peers with a 1.1% decline over a year, its five-year gain hits 66%. Investors are reevaluating the regional airline amid sector-wide capacity and demand shifts. A Discounted Cash Flow (DCF) analysis shows SkyWest's intrinsic value at $210.36 per share, suggesting a 57.5% undervaluation compared to its current price. The price-to-earnings (P/E) ratio stands at 8.43x, matching the airline industry average but trailing a peer average of 30.02x. This valuation contrast points to potential market mispricing, raising questions about the stock's risk and reward balance in the evolving airline landscape.